Sole Source: Osan Air Base, Korea Sysmex Hematology and Coagulation Analyzers
Defense Health Agency · DEFENSE HEALTH AGENCY HCD WEST
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HT941026N0059 in this department, oldest first.
- May 11, 2026 · this noticeSpecial Notice
- Jun 11, 2026Award NoticeSL MEDITECH CO. Seongnam-si GYEONGGI-DO 13103 KOR · $604KOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Notice of Intent to Sole Source HT941026N0059 The objective of this sole source award is to procure equipment installation and implementation of fully functional Sysmex Hematology and Coagulation Analyzers for Osan Air Base, Korea. SL MEDITECH CO is the official importer of the Hematology Analyzers and Blood Coagulation Analyzerd for Sysmex and is proprietary with no authorized provider of this equipment, reagents and consumables, or technical support. There is no reasonable expectation of receiving quotes from two or more small businesses. The proposed acquisition strategy is to justify as an… (show all)
Other Than Full and Open procurement on a sole source basis. See Attached NOI
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY HCD WEST), same product/service code (PSC) 6550 and NAICS 334516.
Single-winner award sizes (3): middle half $1.4M to $3.7M, median $2.7M; range $111K to $4.7M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SYSMEX AMERICA, INC | 2 | $2.8M | Oct 1, 2026 |
| BIOFIRE DEFENSE LLC | 1 | $4.7M | Apr 8, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Oct 1, 2026SYSMEX AMERICA, INC$2.7MFY26 Lab Consolidation for Coagulation CPRR EffortNo listed company matched (Materiality N/A)
- Apr 8, 2026BIOFIRE DEFENSE LLC$4.7MBIOFIRE MOLECULAR ANALYZER AT NHCPNo listed company matched (Materiality N/A)
- Dec 9, 2025SYSMEX AMERICA, INC$111KSole Source - Hematology Analyzer, JBPHHNo listed company matched (Materiality N/A)
Competitive landscape
For the 2 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (9 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.